Georg Lutter Selected Research

Georg Lutter Research Topics

Disease

12	Aortic Valve Stenosis (Aortic Stenosis) 05/2022 - 04/2013
7	Ischemia 05/2006 - 11/2002
5	Hemorrhage 01/2022 - 08/2006
4	Stroke (Strokes) 12/2021 - 06/2003
4	Atrial Fibrillation 12/2021 - 02/2008
3	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 01/2021
3	Left Ventricular Outflow Obstruction 12/2015 - 09/2010
3	Coronary Disease (Coronary Heart Disease) 05/2006 - 12/2002
3	Myocardial Ischemia (Ischemic Heart Diseases) 11/2003 - 12/2002
2	Myocardial Infarction 01/2022 - 12/2021
2	Heart Failure 01/2022 - 01/2020
2	Chronic Obstructive Pulmonary Disease (COPD) 03/2021 - 06/2020
2	Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) 01/2021 - 03/2014
2	Thrombosis (Thrombus) 01/2021 - 04/2017
2	Chronic Renal Insufficiency 01/2021 - 02/2008
2	Coronary Artery Disease (Coronary Atherosclerosis) 12/2002 - 06/2002
1	Pathologic Dilatation (Ectasia) 04/2022
1	Aortitis 04/2022
1	Giant Cell Arteritis (Horton Disease) 04/2022
1	Aortic Dissection 01/2022
1	Pain (Aches) 12/2021
1	Endocarditis 12/2021
1	Emergence Delirium 12/2021
1	Pulmonary Hypertension 05/2021
1	Left Ventricular Dysfunction 03/2021
1	Atrial Flutter (Flutter, Atrial) 01/2021
1	Lung Diseases (Lung Disease) 01/2021
1	Pulmonary Arterial Hypertension 01/2021
1	Frailty 01/2021
1	Peripheral Arterial Disease 06/2020
1	Cardiac Arrhythmias (Arrythmia) 12/2018
1	Mitral Valve Insufficiency (Mitral Regurgitation) 12/2018
1	Hypertrophy 01/2017
1	Body Weight (Weight, Body) 01/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2017
1	Hemolysis 05/2016
1	Pathologic Constriction (Stenosis) 03/2004
1	Reperfusion Injury 03/2003
1	Aneurysm (Aneurysms) 06/2002

Drug/Important Bio-Agent (IBA)

5	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2006 - 11/2002
4	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 01/2020
3	Troponin T (Troponin T1)IBA 01/2022 - 01/2021
3	pro-brain natriuretic peptide (1-76)IBA 03/2021 - 01/2020
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2004 - 01/2003
3	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 11/2003 - 11/2002
2	AlbuminsIBA 01/2022 - 01/2021
2	CreatinineIBA 05/2021 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 11/2003 - 12/2002
1	Indicators and Reagents (Reagents)IBA 04/2022
1	Contrast MediaIBA 04/2022
1	C-Reactive ProteinIBA 01/2022
1	Trinitrotoluene (TNT)IBA 03/2021
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2021
1	Tissue Plasminogen Activator (Alteplase)FDA Link 04/2017
1	Troleandomycin (TAO)FDA Link 01/2017
1	Extracellular Matrix ProteinsIBA 01/2017
1	OsteopontinIBA 01/2017
1	Biological ProductsIBA 09/2014
1	EnzymesIBA 05/2006
1	Complementary DNA (cDNA)IBA 03/2004
1	Proteins (Proteins, Gene)FDA Link 12/2002

Therapy/Procedure

11	Transcatheter Aortic Valve Replacement 01/2022 - 04/2013
9	Therapeutics 04/2022 - 12/2002
8	Stents 01/2021 - 08/2006
2	Operative Surgical Procedures 05/2022 - 06/2002
2	Lasers (Laser) 04/2017 - 03/2004
2	Induced Heart Arrest (Cardioplegia) 06/2003 - 03/2003
2	Transmyocardial Laser Revascularization 01/2003 - 06/2002
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 05/2022
1	Cardiopulmonary Resuscitation (CPR) 05/2022
1	Deep Hypothermia Induced Circulatory Arrest 01/2022
1	Patient Readmission 01/2022
1	Length of Stay 12/2021
1	Thoracotomy 12/2021
1	Tracheotomy 12/2021
1	Blood Transfusion (Blood Transfusions) 06/2020
1	Aftercare (After-Treatment) 01/2017
1	Conservative Treatment 05/2016
1	Bioprosthesis 02/2008
1	Contraindications 02/2008
1	Transplantation 06/2003
1	Injections 12/2002